AstraZeneca Rises; Dagens Industri Says Pfizer May Be Back
2014-08-29 07:44:57.648 GMT
By Allison Connolly
Aug. 29 (Bloomberg) -- AstraZeneca rises as much as 2.5% in
London; Sweden’s Dagens Industri newspaper said there are
“indications” of “discussions of a potential new bid” from
Pfizer, without saying where it obtained that information.
* Vol. in London 14% 3-mo. daily avg.
* Gains as much as 2.7% in Sweden, vol. 55% of 3-mo. daily
avg.
* Calls to AstraZeneca spokesperson weren’t immediately
returned
* Earlier, AstraZeneca’s MEDI-4736 Advances, May Be Multi-
Blockbuster: UBS
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
--With assistance from Niklas Magnusson in Stockholm.
To contact the reporter on this story:
Allison Connolly in London at +44-20-3525-7043 or
aconnolly4@bloomberg.net
To contact the editors responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net
Gaurav Panchal
2014-08-29 07:44:57.648 GMT
By Allison Connolly
Aug. 29 (Bloomberg) -- AstraZeneca rises as much as 2.5% in
London; Sweden’s Dagens Industri newspaper said there are
“indications” of “discussions of a potential new bid” from
Pfizer, without saying where it obtained that information.
* Vol. in London 14% 3-mo. daily avg.
* Gains as much as 2.7% in Sweden, vol. 55% of 3-mo. daily
avg.
* Calls to AstraZeneca spokesperson weren’t immediately
returned
* Earlier, AstraZeneca’s MEDI-4736 Advances, May Be Multi-
Blockbuster: UBS
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
--With assistance from Niklas Magnusson in Stockholm.
To contact the reporter on this story:
Allison Connolly in London at +44-20-3525-7043 or
aconnolly4@bloomberg.net
To contact the editors responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net
Gaurav Panchal